NewAmsterdam Pharma Ownership | Who Owns NewAmsterdam Pharma?
NewAmsterdam Pharma Ownership Summary
NewAmsterdam Pharma is owned by 100.68% institutional investors, 0.89% insiders. Frazier life sciences management is the largest institutional shareholder, holding 14.94% of NAMS shares. American Funds SMALLCAP World A is the top mutual fund, with 8.00% of its assets in NewAmsterdam Pharma shares.
NAMS Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | NewAmsterdam Pharma | 100.68% | 0.89% | -1.57% |
| Sector | Healthcare Stocks | 246.48% | 12.12% | -158.60% |
| Industry | Biotech Stocks | 384.82% | 11.76% | -296.58% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Frazier life sciences management | 18.09M | 14.94% | $613.03M |
| Capital world investors | 12.23M | 10.10% | $414.49M |
| Fmr | 10.34M | 8.54% | $350.41M |
| Ra capital management | 9.55M | 7.89% | $323.66M |
| Fcpm iii services b.v. | 8.49M | 7.01% | $287.74M |
| Deerfield management company, l.p. (series c) | 4.26M | 3.52% | $144.53M |
| Viking global investors lp | 4.20M | 3.47% | $142.46M |
| Bain capital life sciences investors | 3.81M | 3.14% | $129.00M |
| Maverick capital | 3.27M | 2.70% | $110.75M |
| Duquesne family office | 3.07M | 2.54% | $104.05M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Medicxi ventures management (jersey) | 2.18M | 41.90% | $53.07M |
| Fcpm iii services b.v. | 8.49M | 38.34% | $287.74M |
| Frazier life sciences management | 18.09M | 13.35% | $613.03M |
| Bain capital life sciences investors | 3.81M | 7.67% | $129.00M |
| Artia global partners lp | 503.94K | 3.15% | $17.08M |
| Ra capital management | 9.55M | 2.81% | $323.66M |
| Healthinvest partners ab | 248.85K | 2.27% | $8.43M |
| First turn management | 582.50K | 2.11% | $19.74M |
| Duquesne family office | 3.07M | 2.00% | $104.05M |
| Deerfield management company, l.p. (series c) | 4.26M | 1.51% | $144.53M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Orbis allan gray | 1.75M | 0.20% | 1.75M |
| Fmr | 10.34M | 0.02% | 1.57M |
| Price t rowe associates inc /md/ | 1.17M | 0.00% | 1.17M |
| Frazier life sciences management | 18.09M | 13.35% | 1.15M |
| Capital world investors | 12.23M | 0.05% | 1.12M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Wellington management group llp | 218.75K | 0.00% | -4.90M |
| Bain capital life sciences investors | 3.81M | 7.67% | -3.50M |
| Polar capital | 1.72M | 0.14% | -1.11M |
| Siren | - | - | -765.71K |
| Fcpm iii services b.v. | 8.49M | 38.34% | -708.55K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Orbis allan gray | 1.75M | 0.20% | 1.75M | $59.23M |
| Hrt financial lp | 349.84K | 0.02% | 349.84K | $11.86M |
| Exoduspoint capital management, lp | 304.33K | 0.07% | 304.33K | $10.31M |
| Axa investment managers | 196.78K | 0.02% | 196.78K | $5.60M |
| Point72 asset management | 168.90K | 0.01% | 168.90K | $5.72M |
Sold Out
| Holder | Change |
|---|---|
| Gamma investing | -9.00 |
| Kilter group | -9.00 |
| Mai capital management | -11.00 |
| Principal securities | -13.00 |
| Coldstream capital management | -24.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | 212 | 17.13% | 121,923,489 | -1.37% | 100 | 0.86% | 121 | 28.72% | 50 | 4.17% |
| Mar 31, 2026 | 61 | -68.39% | 12,772,651 | -89.23% | 11 | 0.11% | 34 | -69.64% | 14 | -73.08% |
| Dec 31, 2025 | 55 | -62.07% | 12,251,519 | -89.84% | 10 | 0.09% | 32 | -58.44% | 10 | -72.97% |
| Sep 30, 2025 | 43 | -66.67% | 10,963,801 | -90.21% | 9 | 0.10% | 20 | -75.61% | 10 | -62.96% |
| Jun 30, 2025 | 135 | 3.05% | 116,309,195 | 16.74% | 103 | 1.40% | 85 | 11.84% | 28 | -9.68% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| American Funds SMALLCAP World A | 9.56M | 8.00% | 296.89K |
| Vanguard Health Care Inv | 3.95M | 3.38% | 280.70K |
| Capital Group Global Equity Canada F | 2.52M | 2.14% | - |
| Fidelity Contrafund | 2.33M | 1.95% | -762.00 |
| Strategic Advisers Fidelity US TtlStk | 2.29M | 1.92% | 53.51K |
| American Funds New Economy A | 1.25M | 1.04% | 288.62K |
| Jennison SMid Cap Core Equity | 966.54K | 0.84% | -119.37K |
| Fidelity Select Health Care | 980.00K | 0.82% | 132.40K |
| Capital Group New Economy Comp | 957.48K | 0.82% | - |
| Polar Capital Biotech S Inc | 822.83K | 0.69% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Sep 30, 2026 | Kastelein Johannes Jacob Pieter | Chief Scientific Officer | Sell | $1.26M |
| Sep 14, 2026 | Davidson Michael H. | Chief Executive Officer | Buy | $226.50K |
| Sep 04, 2026 | Smither John W | - | Sell | $40.51K |
| Aug 24, 2026 | Kastelein Johannes Jacob Pieter | Chief Scientific Officer | Sell | $3.36M |
| Jul 20, 2026 | Kooij Louise Frederika | Chief Accounting Officer | Sell | $990.03K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q3 | 1 | 6 |
| 2026 Q2 | - | 3 |
| 2026 Q1 | - | 31 |
| 2025 Q4 | - | 3 |
| 2025 Q3 | 3 | 10 |
NAMS Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools